Table 1.

Baseline clinical characteristics of the study subjects

Parameters	HTG group (n = 118)	NTG group (n = 73)	Control group (n = 79)	P for trend
Sex (M/F)	71/47	39/34	40/39	0.382
Age (years)	56.12 ± 8.51	58.23 ± 7.14	56.68 ± 7.70	0.198
BMI (kg/m2)	26.47 ± 4.68a,b	24.78 ± 3.65	24.28 ± 3.50	0.001
SBP (mmHg)	127.51 ± 6.04	126.03 ± 6.81	126.29 ± 6.81	0.235
DBP (mmHg)	75.50 ± 6.49	74.42 ± 7.17	74.10 ± 7.45	0.335
TC (mmol/L)	5.13 ± 1.04	4.99 ± 0.95	4.87 ± 0.92	0.189
HDL-C (mmol/L)	1.34 ± 0.28a,b	1.56 ± 0.38	1.56 ± 0.35	<0.001
LDL-C (mmol/L)	3.10 ± 0.74a	2.92 ± 0.78	2.83 ± 0.77	0.041
TG (mmol/L)	2.37 (1.99, 2.81)a,b	1.18 (0.73, 1.51)	1.03 (0.69, 1.45)	0.015
FFA (mmol/L)	0.67 ± 0.18a,b	0.49 ± 0.15	0.44 ± 0.14	0.023
hsCRP (mg/L)	1.64 (1.04, 2.57)a	1.47 (0.64, 2.63)	1.15 (0.34, 2.38)	0.048
FBG (mmol/L)	6.33 ± 0.49a,b	6.06 ± 0.50a	5.49 ± 0.39	<0.001
2hPG (mmol/L)	9.34 ± 0.88a	9.31 ± 0.89a	6.34 ± 0.73	<0.001
HbA1c (%)	6.30 (6.00, 6.40)a	6.20 (6.00, 6.30)a	5.90 (5.50, 6.10)	<0.001
FINS (mIU/L)	15.50 (10.78, 18.60)a,b	6.80 (5.20, 11.70)	7.53 (5.30, 9.40)	0.001

HTG group impaired glucose tolerance patients with hypertriglyceridemia, NTG group impaired glucose tolerance patients without hypertriglyceridemia; control group, control subjects; BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TG triglycerides, FFA free fatty acids, hsCRP high sensitivity C-reactive protein, FBG fasting blood glucose, 2hPG 2-h postchallenge glucose, HbA1c glycosylated hemoglobin, FINS fasting insulin

^a P < 0.017 (0.05 divided by the number of comparisons), significantly different compared with control group

^b P < 0.017 (0.05 divided by the number of comparisons), significantly different compared with the NTG group